2C-C

2C-C
Clinical data
Other names	2,5-Dimethoxy-4-chlorophenethylamine; 4-Chloro-2,5-dimethoxyphenethylamine
Routes of; administration	Oral
Drug class	Serotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); CA: Schedule III; DE: Anlage I (Authorized scientific use only); US: Schedule I;
Identifiers
	IUPAC name 2-(4-chloro-2,5-dimethoxyphenyl)ethan-1-amine;
CAS Number	88441-14-9 ;
PubChem CID	29979100;
ChemSpider	21106221 ;
UNII	0RO7MZY2LS;
ChEMBL	ChEMBL124733 ;
CompTox Dashboard (EPA)	DTXSID80893699 ;
Chemical and physical data
Formula	C10H14ClNO2
Molar mass	215.68 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	220 to 221 °C (428 to 430 °F) (hydrochloride)
	SMILES COc1cc(CCN)c(cc1Cl)OC;
	InChI InChI=1S/C10H14ClNO2/c1-13-9-6-8(11)10(14-2)5-7(9)3-4-12/h5-6H,3-4,12H2,1-2H3 ; Key:CGKQFIWIPSIVAS-UHFFFAOYSA-N ;
	(verify)

2C-C is a psychedelic drug of the 2C family. It was first synthesized by Alexander Shulgin, sometimes used as an entheogen. In his book PiHKAL (Phenethylamines i Have Known And Loved), Shulgin lists the dosage range as 20–40 mg. 2C-C is usually taken orally, but may also be insufflated.^[1] 2C-C is schedule I of section 202(c) of the Controlled Substances Act in the United States, signed into law as of July, 2012 under the Food and Drug Administration Safety and Innovation Act.^[2]

Not much information is known about the toxicity of 2C-C.

^ Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
^ "S. 3187: Food and Drug Administration Safety and Innovation Act, Subtitle D-Synthetic Drugs". FDA. June 27, 2012. Archived from the original on July 4, 2012. Retrieved July 12, 2012.

[CitePiHKAL-1] Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.

[2] "S. 3187: Food and Drug Administration Safety and Innovation Act, Subtitle D-Synthetic Drugs". FDA. June 27, 2012. Archived from the original on July 4, 2012. Retrieved July 12, 2012.

[1]

[2]